Source: c19study.com

The studies continue to roll out, and there has been very positive results in pre and post exposure as well as early treatment of confirmed COVID-19 patients ( near 100%). There is also considerable efficacy (62%) when treating late. Most studies concur.

Check out c19study.com for the up to date tally on what is evolving. The site is live and constantly updated.
blank

Check out c19study.com for the up to date tally on what is evolving. The site is live and constantly updated.




See Related:
Hydroxychloroquine significantly lowers COVID-19 death rate, Henry Ford Health study finds

NY Study: Risk Factors for Mortality in Patients with COVID-19 in New York City

Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection.

Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as an ambulatory treatment for COVID-19 patients in Cameroon.

Global Research: Media Sabotage of Hydroxychloroquine Use for COVID-19; Doctors Worldwide Protest the Disaster

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Ivermectin Authorised in Indonesia as Pharma Issued License for Production to Battle COVID-19

For months, India’s national authorities have authorized ivermectin as a regimen to be included targeting COVID-19 yet this authorization was then removed due in part to both internal and external political pressure. Now the world’s fourth most populous nation’s regulatory authority has authorised ivermectin’s use in a major breakthrough for the drug’s role in the COVID-19 pandemic.

Read More »